These patients have metabolic dysfunctions in addition to the previously recognized neurodegenerative changes.[51, 52] However, the mechanism of MECP2 in the regulation of glucose and lipid metabolism remains unclear in RTT patients. Here, MECP2 is linked to Rett syndrome.